口腔医学研究 ›› 2023, Vol. 39 ›› Issue (10): 866-870.DOI: 10.13701/j.cnki.kqyxyj.2023.10.003
郎雪莲1,2,3, 胡涛1,2,3*
收稿日期:
2023-03-08
出版日期:
2023-10-28
发布日期:
2023-10-25
通讯作者:
*胡涛,E-mail: hutao@scu.edu.cn
作者简介:
郎雪莲(1997~ ),女,重庆石柱人,硕士在读,医师,研究方向:牙体牙髓病学。
基金资助:
LANG Xuelian1,2,3, HU Tao1,2,3*
Received:
2023-03-08
Online:
2023-10-28
Published:
2023-10-25
摘要: 活髓切断术是临床常规的活髓保存手段,基于微创牙髓治疗的理论,能够最大限度地保存牙齿软硬组织的生理功能。为提高活髓切断术的临床预后,本文综述了近年来活髓切断术相关的基础和临床研究进展,总结了关于活髓切断的临床操作程序,以期为今后临床实践和研究提供一些参考。
郎雪莲, 胡涛. 恒牙活髓切断术-从基础到临床的新进展[J]. 口腔医学研究, 2023, 39(10): 866-870.
LANG Xuelian, HU Tao. Advances of Pulpotomy in Permanent Teeth: from Fundamental to Clinical Application[J]. Journal of Oral Science Research, 2023, 39(10): 866-870.
[1] 刘奕雯,蒋宏伟.活髓保存治疗中的微创理念[J].中华口腔医学研究杂志(电子版),2019,13(4): 193-199. [2] 蒋宏伟.微创牙髓治疗的理论与实践[J].中华口腔医学杂志,2016,51(8):460-464. [3] Pulp therapy for primary and immature permanent teeth [J]. Pediatr Dent, 2018, 40(6):343-351. [4] Wu Y, Zhou C, Tong X, et al. Histochemical localization of putative stem cells in irreversible pulpitis [J]. Oral Dis, 2022, 28(4): 1207-1214. [5] 何文喜,余擎.牙髓炎的活髓保存及再生治疗新进展:从基础到临床[J].中华口腔医学杂志,2022,57(1):16-22. [6] 陈嘉琪,董艳梅.龋源性露髓成熟恒牙活髓保存治疗的研究进展[J].中华口腔医学杂志,2022,57(1):95-100. [7] Asgary S, Hassanizadeh R, Torabzadeh H, et al. Treatment outcomes of 4 vital pulp therapies in mature molars [J]. J Endod, 2018, 44(4): 529-535. [8] Elmsmari F, Ruiz XF, Miró Q, et al. Outcome of partial pulpotomy in cariously exposed posterior permanent teeth: A systematic review and meta-analysis [J]. J Endod, 2019, 45(11): 1296-1306.e1293. [9] Ricucci D, Loghin S, Siqueira JF Jr. orrelation between clinical and histologic pulp diagnoses[J]. J Endod, 2014, 40(12): 1932-1939. [10] Lin LM, Ricucci D, Saoud TM, et al. Vital pulp therapy of mature permanent teeth with irreversible pulpitis from the perspective of pulp biology [J]. Aust Endod J, 2020, 46(1): 154-165. [11] Balevi B. Cold pulp testing is the simplest and most accurate of all dental pulp sensibility tests [J]. Evid Based Dent, 2019, 20(1): 22-23. [12] Mainkar A, Kim SG. Diagnostic accuracy of 5 dental pulp tests: A systematic review and meta-analysis [J]. J Endod, 2018, 44(5): 694-702. [13] Patro S, Meto A, Mohanty A, et al. Diagnostic accuracy of pulp vitality tests and pulp sensibility tests for assessing pulpal health in permanent teeth: A systematic review and meta-analysis [J]. Int J Environ Res Public Health, 2022, 19(15): 9599. [14] Ghouth N, Duggal MS, Kang J, et al. A diagnostic accuracy study of laser doppler flowmetry for the assessment of pulpal status in children's permanent incisor teeth [J]. J Endod, 2019, 45(5): 543-548. [15] 徐倩容.牙髓活力检测的新进展[J].国际口腔医学杂志,2011,38(2): 234-238. [16] 杨靖翚,袁国华.对牙髓活力测试方法的介绍与评价[J].口腔医学研究,2021,37(3): 195-199. [17] Ballal NV, Duncan HF, Wiedemeier DB, et al. MMP-9 levels and NaOCl lavage in randomized trial on direct pulp capping [J]. J Dent Res, 2022, 101(4): 414-419. [18] Chen M, Zeng J, Yang Y, et al. Diagnostic biomarker candidates for pulpitis revealed by bioinformatics analysis of merged microarray gene expression datasets [J]. BMC Oral Health, 2020, 20(1): 279. [19] Sharma R, Kumar V, Logani A, et al. Association between concentration of active MMP-9 in pulpal blood and pulpotomy outcome in permanent mature teeth with irreversible pulpitis- a preliminary study [J]. Int Endod J, 2021, 54(4): 479-489. [20] Aguirre-Lopez EC, Patino-Marin N, Martinez-Castanon GA, et al. Levels of matrix metalloproteinase-8 and cold test in reversible and irreversible pulpitis [J]. Medicine (Baltimore), 2020, 99(52):e23782. [21] Duncan HF. Present status and future directions-Vital pulp treatment and pulp preservation strategies [J]. Int Endod J, 2022, 55 Suppl 3(Suppl 3):497-511. [22] 李修珍,杨芳.活髓切断术的非感觉性牙髓测试方法的应用评价[J].临床口腔医学杂志,2022,38(2): 123-125. [23] Munir A, Zehnder M, Rechenberg DK. Wound lavage in studies on vital pulp therapy of permanent teeth with carious exposures: A qualitative systematic review [J]. J Clin Med, 2020, 9(4):984. [24] Duncan HF, Galler KM, Tomson PL, et al. European society of endodontology position statement: Management of deep caries and the exposed pulp [J]. Int Endod J, 2019, 52(7): 923-934. [25] Hirschberg C, Bogen G, Galicia G, et al. AAE position statement on vital pulp therapy [J]. J Endod, 2021, 47(9): 1340-1344. [26] 周学东,黄定明,刘建国,等. 牙髓损伤的活髓保存治疗 [J]. 华西口腔医学杂志,2017,35(4):339-347 [27] Fathy SM. Remineralization ability of two hydraulic calcium-silicate based dental pulp capping materials: Cell-independent model [J]. J Clin Exp Dent, 2019, 11(4): e360-e366. [28] Giraud T, Jeanneau C, Rombouts C, et al. Pulp capping materials modulate the balance between inflammation and regeneration [J]. Dent Mater, 2019, 35(1): 24-35. [29] Mahgoub N, Alqadasi B, Aldhorae K, et al. Comparison between iRoot BP plus (EndoSequence root repair material) and mineral trioxide aggregate as pulp-capping agents: A systematic review [J]. J Int Soc Prev Community Dent, 2019, 9(6): 542-552. [30] Meschi N, Patel B, Ruparel NB. Material pulp cells and tissue interactions [J]. J Endod, 2020, 46(9): S150-S160. [31] Corral Nunez C, Altamirano Gaete D, Maureira M, et al. Nanoparticles of bioactive glass enhance biodentine bioactivity on dental pulp stem cells [J]. Materials (Basel), 2021, 14(10):2684. [32] 钱锟,潘洁,朱文昊,等.两种硅酸钙类材料用于成熟恒牙牙髓切断术的临床效果[J].北京大学学报(医学版),2022,54(1):113-118. [33] 吴丽娜.生物陶瓷用于年轻恒牙牙髓切断术的效果[J].中国实用医药,2019,14(34):36-38. [34] Uesrichai N, Nirunsittirat A, Chuveera P, et al. Partial pulpotomy with two bioactive cements in permanent teeth of 6-to 18-year-old patients with signs and symptoms indicative of irreversible pulpitis: a noninferiority randomized controlled trial [J]. Int Endod J, 2019, 52(6): 749-759. [35] Torabinejad M, Parirokh M, Dummer PMH. Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview - part Ⅰ: vital pulp therapy [J]. Int Endod J, 2018, 51(2):177-205. [36] Obeid MF, El-Batouty KM, Aslam M. The effect of using nanoparticles in bioactive glass on its antimicrobial properties [J]. Restor Dent Endod, 2021, 46(4): e58. [37] Gong W, Huang Z, Dong Y, et al. Ionic extraction of a novel nano-sized bioactive glass enhances differentiation and mineralization of human dental pulp cells [J]. J Endod, 2014, 40(1): 83-88. [38] Smith AJ, Scheuen BA, Takahashi Y, et al. Dentine as a bioactive extracellular matrix [J]. Arch Oral Biol, 2012, 57(2): 109-121. [39] Gavio-Ordua JF, Caviedes-Bucheli J, Manzanares-Céspedes MC, et al. Dentin growth after direct pulp capping with the different fractions of plasma rich in growth factors (PRGF) vs. MTA: experimental study in animal model [J]. J Clin Med, 2021, 10(15):3432. [40] 胡光耀.PRF膜、氢氧化钙和MTA在牙髓切断术中的疗效[J].北华大学学报(自然科学版),2019,20(5):686-688. [41] 胡光耀.PRF在年轻恒牙牙髓切断术中的应用[J].北华大学学报(自然科学版),2020,21(6):790-792. [42] Awawdeh L, Al-Qudah A, Hamouri H, et al. Outcomes of vital pulp therapy using mineral trioxide aggregate or biodentine: A prospective randomized clinical trial [J]. J Endod, 2018, 44(11): 1603-1609. [43] Careddu R, Duncan HF. A prospective clinical study investigating the effectiveness of partial pulpotomy after relating preoperative symptoms to a new and established classification of pulpitis [J]. Int Endod J, 2021, 54(12): 2156-2172. [44] Eshghi A, Hajiahmadi M, Nikbakht MH, et al. Comparison of clinical and radiographic success between MTA and biodentine in pulpotomy of primary mandibular second molars with irreversible pulpitis: A randomized double-blind clinical trial [J]. Int J Dent, 2022, 2022:6963944. [45] Hamilton A, Clarkson JE, Ramsay CR, et al. Pulpotomy for the management of irreversible pulpitis in mature teeth (PIP): a feasibility study [J]. Pilot Feasibility Stud, 2022, 8(1):77. [46] Hussain MI, Bashar AM. Outcome of mineral trioxide aggregate pulpotomy for mature permanent molars with symptoms indicative of irreversible pulpitis [J]. Mymensingh Med J, 2022, 31(1): 223-229. [47] Koli B, Chawla A, Logani A, et al. Combination of nonsurgical endodontic and vital pulp therapy for management of mature permanent mandibular molar teeth with symptomatic irreversible pulpitis and apical periodontitis [J]. J Endod, 2021, 47(3): 374-381. [48] Shallal-Ayzin M, Trinh T, Yeung W, et al. A prospective analysis of the correlation between postoperative pain and vital pulp therapy [J]. Front Dent Med, 2021, 2: 647417. [49] Taha NA, Abdelkhader SZ. Outcome of full pulpotomy using Biodentine in adult patients with symptoms indicative of irreversible pulpitis [J]. Int Endod J, 2018, 51(8): 819-828. [50] Taha NA, Khazali MA. Partial pulpotomy in mature permanent teeth with clinical signs indicative of irreversible pulpitis: A randomized clinical trial [J]. J Endod, 2017, 43(9): 1417-1421. [51] Tan SY, Yu VSH, Lim KC, et al. Long-term pulpal and restorative outcomes of pulpotomy in mature permanent teeth [J]. J Endod, 2020, 46(3): 383-390. [52] Yong D, Cathro P. Conservative pulp therapy in the management of reversible and irreversible pulpitis [J]. Aust Dent J, 2021, 66: S4-S14. [53] Palma PJ, Marques JA, Falacho RI, et al. Does delayed restoration improve shear bond strength of different restorative protocols to calcium silicate-based cements? [J]. Materials (Basel), 2018, 11(11): 2216. [54] Munoz-Sanchez M-L, Linas N, Decerle N, et al. A combination of full pulpotomy and chairside CAD/CAM endocrown to treat teeth with deep carious lesions and pulpitis in a single session: A preliminary study [J]. Int J Environ Res Public Health, 2020, 17(17):6340. [55] Santos JM, Pereira JF, Marques A, et al. Vital pulp therapy in permanent mature posterior teeth with symptomatic irreversible pulpitis: A systematic review of treatment outcomes [J]. Medicina (Kaunas), 2021, 57(6):573. [56] Taha NA, Al-khatib H. 4-year follow-up of full pulpotomy in symptomatic mature permanent teeth with carious pulp exposure using a stainproof calcium silicate- based material [J]. J Endod, 2022, 48(1): 87-95. [57] Ather A, Patel B, Gelfond JAL, et al. Outcome of pulpotomy in permanent teeth with irreversible pulpitis: a systematic review and meta-analysis [J]. Sci Rep, 2022, 12(1): 19664. [58] Rechithra R, Aravind A, Kumar V, et al. Influence of occlusal and proximal caries on the outcome of full pulpotomy in permanent mandibular molar teeth with partial irreversible pulpitis: A prospective study [J]. Int Endod J, 2021, 54(10): 1699-1707. [59] Duncan HF, Chong BS, Del Fabbro M, et al. The development of European Society of Endodontology S3-level guidelines for the treatment of pulpal and apical disease [J]. Int Endod J, 2021, 54(5): 643-645. [60] Beauquis J, Setbon HM, Dassargues C, et al. Short-term pain evolution and treatment success of pulpotomy as irreversible pulpitis permanent treatment: A non-randomized clinical study [J]. J Clin Med, 2022, 11(3):787. [61] Eghbal MJ, Haeri A, Shahravan A, et al. Postendodontic pain after pulpotomy or root canal treatment in mature teeth with carious pulp exposure: A multicenter randomized controlled trial [J]. Pain Res Manag, 2020, 2020:5853412. [62] Baranwal HC, Mittal N, Yadav J, et al. Outcome of partial pulpotomy verses full pulpotomy using biodentine in vital mature permanent molar with clinical symptoms indicative of irreversible pulpitis: A randomized clinical trial [J]. J Conserv Dent, 2022, 25(3): 317-323. |
[1] | 陈河林, 舒佳玉, 董强. CENPN对头颈鳞状细胞癌患者预后的预测价值研究[J]. 口腔医学研究, 2023, 39(8): 690-695. |
[2] | 杨可, 孙雅楠, 胡雅英, 吕宜楠, 郑小风, 李易玮, 张佳莉. cyclin D1表达模式深度学习识别和预测模型对HPV阴性口腔鳞状细胞癌和口咽鳞状细胞癌患者预后的预测作用[J]. 口腔医学研究, 2023, 39(4): 308-315. |
[3] | 蒋志敏, 马国武, 孙波. Nomogram预测根治性切除局部晚期口腔鳞状细胞癌患者的预后[J]. 口腔医学研究, 2023, 39(1): 56-61. |
[4] | 钟婉金, 李月梅, 陈婵婵, 常惠惠, 丁桂聪. iRoot BP Plus乳磨牙活髓切断术3年疗效观察[J]. 口腔医学研究, 2022, 38(7): 669-672. |
[5] | 张慧, 姜文敬, 王梦瑶, 李林林, 闫波, 高黎. 68例儿童恒牙外伤预后的回顾性研究[J]. 口腔医学研究, 2022, 38(7): 678-681. |
[6] | 吕宜楠, 胡雅英, 郑小风, 杨可, 张佳莉. IL-12A和EBI3在OSCC中的表达及其与免疫微环境的关系[J]. 口腔医学研究, 2022, 38(6): 533-539. |
[7] | 齐元莉, 闫红娟, 祖木热提古丽·阿不来提, 张超杰, 赵举红, 徐江. 口腔鳞状细胞癌中CASZ1的表达及临床意义[J]. 口腔医学研究, 2022, 38(1): 30-33. |
[8] | 周伟, 汤雅, 李厚轩, 陈斌, 闫福华. 牙周牙髓联合病变患牙预后观察的回顾性研究[J]. 口腔医学研究, 2021, 37(9): 825-829. |
[9] | 张旭, 刘佳文. MMP-9、COX-2、NF-κB在口腔鳞状细胞癌组织中的表达及意义[J]. 口腔医学研究, 2021, 37(4): 360-365. |
[10] | 杨凯成, 杨蕾, 赵建广, 罗风玉, 陈彦平, 崔子峰, 陈赫, 满莎莎. 口腔鳞状细胞癌患者外周血microRNA的表达及预后意义[J]. 口腔医学研究, 2020, 36(5): 428-432. |
[11] | 孙振龙, 薛鹏, 遆云飞. 牙根发育完成自体牙移植远期预后及影响因素分析[J]. 口腔医学研究, 2020, 36(5): 449-453. |
[12] | 邹会会, 徐文光, 尹西腾, 韩伟, 江琳琳. 基于SEER数据库分析影响大唾液腺腺样囊性癌患者预后的临床病理因素[J]. 口腔医学研究, 2020, 36(2): 167-171. |
[13] | 张曙光, 王玉龙, 徐文光, 尹西腾, 韩伟, 邹会会. 基于SEER数据库的唾液腺粘液表皮样癌预后因素分析[J]. 口腔医学研究, 2020, 36(10): 915-920. |
[14] | 郭俊峰, 张纲, 谭颖徽. CYP27B1在口腔鳞状细胞癌中的表达及其与预后的关系[J]. 口腔医学研究, 2020, 36(10): 930-933. |
[15] | 魏云鹏, 赵苏峰. 牙源性黏液瘤9例[J]. 口腔医学研究, 2020, 36(10): 934-937. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||